IO Biotech to Present at the 45th Annual Cowen Health Care Conference
Presentation will include an update on the development and launch preparations of Cylembio™ (imsapepimut and etimupepimut, adjuvanted)NEW YORK, ...
Merck & Co. Inc. stock outperforms competitors on strong trading day
This was the stock's third consecutive day of gains.
MRK INVESTOR DEADLINE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 20, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, ...
Korea Joongang Daily on MSN13h
Merck CCO confident of Korea's position in chip sector
Merck Chief Commercial Officer Anand Nambiar spoke positively about Korea's unfaltering chip production capacity at a press ...
VYM: A Moderate Growth Fund That Has Some Flaws
Vanguard High Dividend Yield Index Fund ETF Shares is a conservative growth fund. See why VYM's limited tech exposure impacts ...
Besremi Achieves Strong Market Growth Amid Rising Demand For Polycythemia Vera Treatment
BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...